Louisbourg Investments Inc. Lowers Stock Holdings in Agilent Technologies, Inc. $A

Louisbourg Investments Inc. lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 26.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 35,874 shares of the medical research company’s stock after selling 12,946 shares during the period. Louisbourg Investments Inc.’s holdings in Agilent Technologies were worth $4,881,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of A. Compagnie Lombard Odier SCmA bought a new position in shares of Agilent Technologies in the fourth quarter worth about $1,157,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in Agilent Technologies by 288.9% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,463 shares of the medical research company’s stock valued at $1,696,000 after purchasing an additional 9,258 shares during the period. Nilsine Partners LLC raised its stake in Agilent Technologies by 1.4% during the 4th quarter. Nilsine Partners LLC now owns 9,655 shares of the medical research company’s stock valued at $1,314,000 after purchasing an additional 130 shares during the period. My Personal CFO LLC purchased a new position in Agilent Technologies in the 4th quarter worth approximately $478,000. Finally, Nisa Investment Advisors LLC lifted its holdings in Agilent Technologies by 2.8% in the 4th quarter. Nisa Investment Advisors LLC now owns 91,353 shares of the medical research company’s stock worth $12,430,000 after purchasing an additional 2,482 shares in the last quarter.

Agilent Technologies Stock Performance

NYSE:A opened at $115.44 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27. The stock’s 50 day simple moving average is $121.67 and its two-hundred day simple moving average is $134.51. The company has a market cap of $32.62 billion, a price-to-earnings ratio of 25.48, a PEG ratio of 2.41 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the prior year, the company posted $1.31 earnings per share. The firm’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is 22.52%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on A. Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. The Goldman Sachs Group began coverage on shares of Agilent Technologies in a report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 target price on the stock. HSBC initiated coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price for the company. TD Cowen cut their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, UBS Group reduced their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $161.20.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.